Yet with two market sensitive news releases our way, that company still easily outperformed Novogen on the ASX today - in terms of both value and share price movement.
Maybe tomorrow may prove different.
But thus far we've learned more about you when you bag NOX than anything else.
- Forums
- ASX - By Stock
- KZA
- Ann: In-licencing of Phase II-ready molecule - presentation-NRT.AX
Ann: In-licencing of Phase II-ready molecule - presentation-NRT.AX, page-25
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)